Patoulias D. Letter to the Editor: novel antidiabetic drugs and the risk for hepatocellular carcinoma. What else to expect from these "wonderful" drug classes? Hepatology 2023 Feb 3. doi: 10.1097/HEP.0000000000000311.
PMID: 36724447